Dci-Biolafitte LLC is categorized under Commercial Biotechnical Research in Saint Cloud, MN and active since 2006.
Dci-Biolafitte LLC was established in 2006, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Jeffrey Keller at the company’s single location by writing to 600 54th Avenue North, Saint Cloud, Minnesota MN 56303 or by phoning (320) 257-4378. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Dci-Biolafitte LLC |
Contact Person: | Jeffrey Keller |
Address: | 600 54th Avenue North, Saint Cloud, Minnesota 56303 |
Phone Number: | (320) 257-4378 |
Website Address: | dci-bio.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2006 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Biotechnical Research |
SIC Code: | 8731 |
NAICS Code: | 541711 |
Share This Business: |
Dci-Biolafitte LLC was started in 2006 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jeffrey Keller for inquiries that concern Dci-Biolafitte LLC by calling the company number (320) 257-4378, as your correspondence is most welcome. Additionally, the physical location of the single location of Dci-Biolafitte LLC can be found at the coordinates 45.563867,-94.228933 as well as the street address 600 54th Avenue North in Saint Cloud, Minnesota 56303.
For its online presence, you may visit Dci-Biolafitte LLC’s website at dci-bio.com and engage with its social media outlets through on Twitter and on Facebook.